$TLOG #1 Medivir Strengthens Its Clinical Pipeline by Entering into Agreement to Acquire a Portfolio of Clinical Stage Oncology Programs
BusinessWire - Wed Nov 2, 3:51PM CDT
Regulatory News:
TLOG : 0.0425 (-15.67%) MVRBF : 10.1000 (+1.00%)
(0)
(0)
TetraLogic Pharmaceuticals Corporation (TLOG) Stock Research Links